Acquisition of resistance to antitumor alkylating agent ACNU: A possible target of positron emission tomography monitoring

Nuclear Medicine and Biology

Volumn 33, Issue 1, 2006, Pages 29-35

  Kawai, Hideya ^a,c   Toyohara, Jun ^a,b   Kado, Hirotsugu ^c   Nakagawa, Takao ^a   Takamatsu, Shinji ^a   Furukawa, Takako ^a   Yonekura, Yoshiharu ^a   Kubota, Toshihiko ^a   Fujibayashi, Yasuhisa ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

Drug resistance; FDG; FLT; Glioma; PET; Thymidine

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE; THYMIDINE; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA ALKYLATION; DNA SYNTHESIS; DRUG EFFECT; DRUG UPTAKE; GLIOMA CELL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; CELL SURVIVAL; DIDEOXYNUCLEOSIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; FLUORODEOXYGLUCOSE F18; GLIOMA; NIMUSTINE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RATS; TREATMENT OUTCOME;

EID: 31844451382     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.10.002     Document Type: Article

References (27)

1. C. Haioun, E. Itti, A. Rahmouni, M. Meignan, and F. Reyes PET scan in the therapeutic strategy Hematol J 5 Suppl 3 2004 S149 S153
2. G. Vaidyanathan, and M.R. Zalutsky Imaging drug resistance with radiolabeled molecules Curr Pharm Des 10 24 2004 2965 2979
3. J. Gaa, E.J. Rummeny, and M.D. Seemann Whole-body imaging with PET/MRI Eur J Med Res 9 6 2004 309 312
4. 18F]FLT and positron emission tomography Nat Med 4 11 1998 1334 1336
5. 18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice J Nucl Med 45 10 2004 1754 1758
6. 18F-FDG for differentiating tumor from inflammation in a rodent model J Nucl Med 45 4 2004 695 700
7. 18F-FDG J Nucl Med 44 9 2003 1426 1431
8. H. Barthel, M.C. Cleij, D.R. Collingridge, O.C. Hutchinson, S. Osman, and Q. He 3′-Deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 13 2003 3791 3798
9. S. Shibui Randomized controlled trial on malignant brain tumors - activities of the Japan Clinical Oncology Group-Brain Tumor Study Group Neurol Med Chir (Tokyo) 44 4 2004 220 221
10. Y. Saito, T. Hotta, T. Mikami, K. Kurisu, K. Kawamoto, and K. Kiya Establishment of ACNU-resistant rat gliosarcoma cell lines and their characteristics Neurol Med Chir (Tokyo) 31 13 1991 846 852
11. 6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea Proc Natl Acad Sci U S A 87 24 1990 9883 9887
12. 6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains Acta Neurochir (Wien) 103 1-2 1990 62 66
13. 6-methylguanine residues in DNA Nature 280 5717 1979 76 77
14. M. Kabuto, T. Kubota, H. Kobayashi, T. Nakagawa, and R. Kitai The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution Neurosurgery 37 3 1995 471 476 [discussion 476-7]
15. 6-methylguanine-DNA methyltransferase mRNA in human brain tumors Biochim Biophys Acta 1289 1 1996 105 109
16. D. Ayusawa, K. Shimizu, H. Koyama, S. Kaneda, K. Takeishi, and T. Seno Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate J Mol Biol 190 4 1986 559 567
17. Y. Takamiya, Y. Abe, Y. Tanaka, A. Tsugu, M. Kazuno, and Y. Oshika Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts Br J Cancer 76 4 1997 445 450
18. J. Wang, Z. Chen, X. Xia, D. Lu, J. Xue, and C. Ruan Improvement of combination chemotherapy tolerance by introduction of polycistronic retroviral vector drug resistance genes MGMT and MDR1 into human umbilical cord blood CD34+ cells Leuk Res 26 3 2002 281 288
19. J. Engelbergs, J. Thomale, and M.F. Rajewsky Role of DNA repair in carcinogen-induced ras mutation Mutat Res 450 1-2 2000 139 153
20. 6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysis Neurol Res 25 3 2003 241 248
21. K.A. Krohn, D.A. Mankoff, and J.F. Eary Imaging cellular proliferation as a measure of response to therapy J Clin Pharmacol 2001 Suppl 2001 96S 103S
22. X.B. Kong, Q.Y. Zhu, P.M. Vidal, K.A. Watanabe, B. Polsky, and D. Armstrong Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro- 3′-deoxythymidine and 3′-azido-3′-deoxythymidine Antimicrob Agents Chemother 36 4 1992 808 818
23. J.S. Rasey, J.R. Grierson, L.W. Wiens, P.D. Kolb, and J.L. Schwartz Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells J Nucl Med 43 9 2002 1210 1217
24. J.R. Grierson, J.L. Schwartz, M. Muzi, R. Jordan, and K.A. Krohn Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: validation for positron emission tomography Nucl Med Biol 31 2004 829 837
25. 18F] fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules Cancer Res 62 12 2002 3331 3334
26. 3H] arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines Nucl Med Biol 29 3 2002 281 287
27. 18F] FLT uptake after chemotherapy: an experimental study Eur J Nucl Med Mol Imaging 29 11 2002 1462 1469